title: Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
abstract: The aim of this study was to investigate the correlation between the histologic invasiveness (histologic stage) and various cell proliferation activity assays (quantity of argyrophil proteins associated with nucleolar organizer regions [AgNORs], mitotic activity, MIB1 [Ki67] immunohistochemical detection) for predicting the biologic behavior of malignant canine mammary tumors. Sixty specimens from malignant canine mammary tumors with no distant metastases (M0) at surgery were selected, and follow-up data were collected over a 2-year period. The histologic invasiveness was graded by histologic stage (stage 0 = tumors without stromal invasion; stage I = tumors with stromal invasion; stage II = tumors with neoplastic emboli in vessels), and the proliferative indices were expressed as MIB1 index (the percentage of nuclear area immunohistochemically stained by MIB1 antibody), mitotic index (the number of mitoses per 1,000 neoplastic cells), and AgNOR index (the ratio between mean AgNOR area of tumor cells and the mean AgNOR area of fibroblasts/lymphocytes). The measures of proliferative activity were compared among groups with different histologic stages, and the influence of different prognostic variables (histologic stage, AgNOR index, mitotic index, MIB1 index) on survival time was evaluated. A significant difference in the proliferation patterns was recorded between the different histologic stages for the mitotic index (P = 0.0006) and MIB1 index (0.0013). Among the different parameters considered, histologic stage (P < 0.05), AgNOR index (P = 0.0291), and MIB1 index (P = 0.014) revealed a significant association with prognosis in univariate analysis. AgNOR index for 1-year survival and histologic stage for 2-year survival were the most significant parameters influencing survival, as determined by multiple nonlinear logistic regression.
authors.affiliation: Department of Veterinary Public Health and Animal Pathology, Division of Veterinary Pathology, via Tolara di Sopra 50-40064 Ozzano Emilia, Bologna, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Sarli
authors.forename: Rosario
authors.initials: R
authors.lastname: Preziosi
authors.forename: Cinzia
authors.initials: C
authors.lastname: Benazzi
authors.forename: Gastone
authors.initials: G
authors.lastname: Castellani
authors.forename: Paolo Stefano
authors.initials: PS
authors.lastname: Marcato
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000401:mortality / Q000473:pathology; D000818:Animals; D002455:Cell Division; D004283:Dog Diseases / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology*; D004285:Dogs; D005260:Female; D008321:Mammary Glands, Animal / Q000473:pathology; D015674:Mammary Neoplasms, Animal / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology*; D008940:Mitotic Index; D009367:Neoplasm Staging / Q000662:veterinary; D011379:Prognosis; D016019:Survival Analysis; D013997:Time Factors